Companion Animal Healthcare Market is Growing Massively till 2023

 The exclusive research report on the Global Companion Animal Healthcare Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

Companion Animal Healthcare Market is expected to grow at approximately 9.6% CAGR and reach $20 billion by 2023, according latest Global Companion Animal Healthcare Market Analysis Report published by Market Research Future. Companion animals are pets which are kept for protection of a person, company, property or residence. Companion Animal Healthcare market is segmented by Product (Feed Additives, Pharmaceuticals and Vaccines), Diagnostic Tests (Diagnostic Imaging, Immunodiagnostic Tests, Molecular Diagnostics, others), End Users, and region.

Major Companion Animal Healthcare Companies covered in the market report include Zoetis Animal Healthcare (U.S.), Merck and Co., Inc. (U.S.), Ceva Animal Healthcare (U.K), Virbac Animal Healthcare (France), Merial (France), Elanco Animal Health (U.S.), Bayer Animal Health (Germany), Vetoquinol S.A. (France), Perrigo Company plc (Ireland), and Boehringer Ingelheim (Germany).

Also Read : https://www.medgadget.com/2019/07/at-9-6-cagr-companion-animal-healthcare-market-to-hit-20-billion-by-2023.html  

Global Market Highlights:

Market Research Future (MRFR)’s latest study has revealed that the global companion animal healthcare market is poised to proliferate rapidly at a CAGR of 9.6% during the forecast period 2019 to 2023. The market is set to grow from USD 14 Bn in 2016 to USD 20 Bn in 2023. The growing trend of pet adoption is likely to fuel demand in the companion animal healthcare market as it provides a sense of belongingness and responsibility to the people. The exponential geriatric population has accelerated the rate of pet adoption in the recent times. The trend is anticipated to perpetuate across the assessment period.

The major factors driving the market are increasing companion animal owner demands, increasing companion animal owner awareness, and expectations for companion animal care. Furthermore, companion animal healthcare products, including pharmaceuticals and vaccines, which contribute significantly to the health and wellbeing of these animals. Rise in the income levels of individuals leveraging to the recent trends is leading to the increase in the number of pet (companion animal) adoption which ultimately leads to increase in the demand of companion animal healthcare. New trends of nuclear families and increasing average income among individuals have resulted in increased adoption of pets among middleclass families as well. Increased awareness regarding animal cruelty has also influenced people awareness and ideologies towards animals. Additionally, advances in animal health medicines and vaccines, increased types of medical treatment are fostering the market growth of companion animal healthcare market.

The increasing inclination of the pet owners towards a healthy lifestyle of their companions is projected to catapult the companion animal healthcare market on an upward trajectory. The growing number of nuclear families has paved the way for a rise in pet adoption and expenditure among the middle-class families, which is prognosticated to favor the growth of the market over the next couple of years.

Companion Animal Healthcare Market Segments:

By product, the global Companion animal healthcare market has been segmented into feed additives, pharmaceuticals, and vaccines.

By diagnostic tests, the companion animal healthcare market is segmented into diagnostic imaging, immunodiagnostic tests, molecular diagnostics, and other tests.

By end-users, the global companion animal healthcare market has been segmented into veterinary hospitals, veterinary clinics, and home care.

Regional Analysis:

Globally, America accounts for the largest market share. Rising awareness about companion animal health, availability of wide range of products for animal health, increase in focus on food safety and increase in number of people having pets drive this market. Alarming occurrences of zoonotic diseases also affect the growth of this market. Europe is the second largest market for companion animal healthcare. Increased awareness regarding animal cruelty and ideologies towards animals are some of the major factor driving the growth of this market in Asia Pacific.

The companion animal healthcare market shows a slow growth in Middle East & Africa. Middle East & African market for companion animal healthcare also shows high growth opportunities due financial improvement and related increments in disposable income.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/companion-animal-Healthcare-market-1168 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Amanora Chambers,

Magarpatta Road, Hadapsar

Pune – 411028

Maharashtra, India+1 646 845 9312

sales@marketresearchfuture.com

 

 

Smart Contact Lenses Market to Perceive Momentous Accruals with a hefty CAGR By 2023

 An expert on premium research reports, Market Research Future has added a report titled "Global Smart Contact Lenses Market 2023" to its offering.

The recent study published by Market Research Future (MRFR) reveals that the global smart contact lenses market is set to thrive at a CAGR of 10.4% during the forecast period 2017 to 2023. The valuation of the global market is expected to grow from USD 4.5 Bn in 2016 to USD 7.2 Bn towards the end of 2023. These devices offer various advantages such as continuous monitoring of various health indicators which is anticipated to expedite its adoption globally.

The changing trends in consumer behavior have accelerated the sales of contact lenses. The rising burden of diabetes and technological innovations have paved the way for smart contact lenses into the market.  Smart contact lenses have sensors for the detection of glucose levels in tears and intraocular pressure. Furthermore, the ongoing trend of using medical devices is further expected to boost the growth trajectory of the global smart contact lenses market.

Investments are likely to flow towards innovation of products and addition of features to the lenses. The growing research & development activities are presumed to augment the market presence of smart contact lenses over the next few years. However, the expensiveness of these products is set to check the proliferation of the smart contact lenses market. In addition, the robust competition existing in the market restricts the entry of new participants, thus, holding its growth.

Also Read : https://www.medgadget.com/2019/01/smart-contact-lenses-market-to-worth-over-7-2-bn-with-10-4-cagr-up-to-2023-technology-snapshot-with-solution-to-drive-market-growth-vigorously-by-mrfr.html 

Smart Contact Lenses Industry Update:

March 2018 Theraoptix recently took home the MIT Sloan Healthcare Innovation Prize at their annual competition’s and also received a $25,000 grand prize which was sponsored by Optum, a health services firm. The contact lens is made from FDA-approved materials and delivers eye medication in a sustained and controlled release. The lens is sandwiched between contact lens material which is a drug-filled polymer film and shaped into a tiny circular strip that does not interfere with the wearer’s vision. The sandwiching structure allows the drugs to seep from the film into the eye gradually.

Smart Contact Lenses Industry Segments

On the basis of application, the global smart contact lenses market has been segmented into continuous glucose monitoring, intraocular pressure monitoring and other applications (cholesterol detection, sodium detection, and alcohol detection).

On the basis of end users, the smart contact lenses market has been segmented into hospitals, clinics, and home care settings.

Global Smart Contact Lenses Market Players

Some of the key players profiled in this report are Samsung (South Korea), Alcon (U.S), Google (U.S), Sony (Japan), Sensimed SA (Switzerland).

Samsung is a multinational conglomerate company manufacturing wide range of products. In April 2016, the company received a patent for smart contact lenses with in-built camera in South Korea.

Industry News:

In October 2018, Verily, formerly part of Google, and Novartis’ eye-care division Alcon halted their partnership of developing glucose-sensing smart contact lenses.

In November 2018, VSPARTICLE, a Dutch startup has claimed to develop a low-cost technology for printing sensors that enables smart contact lenses to perform different applications such as glucose sensing, bio-marker sensing, etc.

In November 2018, scientists in Belgium and Japan along with SEED, which is a Japan-based maker of contact lenses have developed soft smart contact lens with an integrated RF antenna, LED microchip, and stretchable interconnections.

In October 2018, LG Group, a South Korean multinational company, has initiated smart contact lenses as its convergent research & development project.

 Regional Analysis:

The global smart contact lenses market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas has control over the largest share of the global market and is expected to retain its market position through the forecast period. The rising burden of diabetes in the region is fueling the demand for the product. As per American Diabetes Association’s analysis in 2015, 30.3 million Americans had diabetes. Other factors responsible for the expansion of smart contact lenses market are technological developments in the eye care industry, accelerated adoption of wearable devices, etc. Furthermore, the presence of key players and rising awareness about fitness are projected to favor the growth of the market.

Europe stands at the second spot in the global smart contact lenses market and is poised to grow substantially in the forthcoming years. The rising investments in smart medical devices are anticipated to propel the expansion of the regional market. Furthermore, the high adoption rate of smart contact lenses and the increasing burden of diabetes are projected to pave the way for market growth over the assessment period.

Asia Pacific exhibits tremendous potential owing to the large-scale prevalence of chronic diseases. However, the high cost of these lenses remains an impediment to the expansion of the smart contact lenses market in the region. Thus, the market is expected to witness steady growth across the review period. The fast-developing economies such as India and China are predicted to emerge as growth pockets of the regional market.

The Middle East & Africa is set to exhibit limited growth in the upcoming years due to limited technological penetration.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/smart-contact-lenses-market-1186

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Global In-Vitro Diagnostics Market Research Report 2020 Analysis and Forecast to 2023

 This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global In-Vitro Diagnostics Market over the forecast period.

The MRFR’s new report titled “In-Vitro Diagnostics Market Research Report – Forecast to 2023” is an expert analysis report which summarizes Market Scenario by recent industry shares, size, progress, demand, regional overview with top leading players analysis.

The Global In-Vitro Diagnostics Market is expected to exhibit a strong 8.16% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The Global In-Vitro Diagnostics Market is mainly driven by the growing government support for healthcare research into discovering more potent, more accurately targeted medication for various diseases. This is likely to drive significant innovation in the healthcare research sector in the coming years, thus driving the In-Vitro Diagnostics Market over the forecast period.

Also Read : https://www.medgadget.com/2019/09/in-vitro-diagnostics-industry-overview-by-top-10-global-leaders-ivd-market-size-share-revenue-trends-and-growth-2023-exclusive-reportage-by-mrfr.html 

The report presents an analysis of the regional segmentation of the market in detail, covering North America, Europe, Asia Pacific, the Middle East, and Latin America to provide a comprehensive overview of the market dynamics in each region. Competitive leaderboard analysis is also done for the market by profiling the leading players in the global In-Vitro Diagnostics Market.

The market is expected to grow substantially in the developing nations over the next couple of years. However, on the contrary, the lack of favorable reimbursement policies remains an impediment to market growth.

There has been a surge in the preference for personalized medicine which has contributed significantly to the market growth. Utilization of advanced diagnostic techniques helps to tailor treatment and therapeutics as per a patient’s genetic profile to offer the best and appropriate treatment for speedy recovery. This has further accelerated the growth of the global in-vitro diagnostics market.

On the other hand, lack of favorable reimbursement scenario for in-vitro diagnostics is expected to restrain the growth of the market. Additionally, varying international structures restrict the effective implementation of strategies on a global scale. Meanwhile, the developing countries present significant growth opportunities for market expansion due to towering demand for advanced diagnostic services.

Key Players – In-Vitro Diagnostics Market

The key players operating in the Global In-Vitro Diagnostics Market and profiled in this MRFR report are

Leading players in the Global In-Vitro Diagnostics Market include

• Danaher Corporation,
• Bio-Rad Laboratories Inc.,
• Siemens AG,
• F. Hoffman-La Roche AG,
• Ortho Clinical Diagnostics,
• Grifols S.A.,
• Qiagen N.V.,
• BioMerieux S.A.,
• Sysmex Corporation,
• Becton Dickinson and Company,
• DiaSorin S.p.A.,
• Abbott Laboratories, and
• Thermo Fisher Scientific.

Segmentations – In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics Market is segmented on the basis of product type, technology, application, end use, and region.

By product, the Global In-Vitro Diagnostics Market is segmented into reagents and kits, instruments, data management software, and services. The reagents and kits segment is likely to establish dominance in the global In-Vitro Diagnostics Market over the forecast period due to the need to replenish reagents and kits on a regular basis.

By technology, the is segmented into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, microbiology, and hematology. Clinical chemistry holds the largest share in the global In-Vitro Diagnostics Market, followed closely immunoassay/immunochemistry.

By application, the Global market is segmented into infectious diseases and non-infectious diseases.

By end use, the Global market is segmented into hospitals, research laboratories, and academic institutions

Regional Analysis – In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics Market is likely to be dominated by North America in the coming years due to the strong presence of research laboratories in the medical field in the region. The growing presence of the healthcare research industry in North America is likely to be the major driver for the Global Market over the forecast period. Growing cancer research is likely to be a major driver for the global market over the forecast period. The growing presence of cancer research organizations in the U.S. is likely to be a major driver for the North America In-Vitro Diagnostics Market over the forecast period.

Europe is also likely to be a major regional market for players in the global In-Vitro Diagnostics Market. Growing cancer research as well as other medical research is likely to be the major driver for the In-Vitro Diagnostics Market in the region over the forecast period. Growing government support for the healthcare sector in this region is likely to remain a key driver for the global In-Vitro Diagnostics Market over the forecast period.

Asia Pacific is expected to advance at a rapid pace in the global In-Vitro Diagnostics Market over the forecast period. Growing presence of the healthcare sector in the region is likely to be a major driver for the In-Vitro Diagnostics Market in Asia Pacific over the forecast period. The medical research industry has emerged as a promising giver of jobs in the Asia Pacific region over the last few years, resulting in steady growth of the In-Vitro Diagnostics Market in Asia Pacific. The growing government investment in setting up facilities that could help the nation in critical times such as disease epidemics is likely to be a key driver for the In-Vitro Diagnostics Market in Asia Pacific over the forecast period. Many governments in the region have presented significant scope for medical research and healthcare innovation to prosper, leading to a growing demand from the In-Vitro Diagnostics Market in the region.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/in-vitro-diagnostics-market-1165 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Organ Transplantation Market – A market with high CAGR and return on investment by 2023

 Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Organ Transplantation Market Research Report - Forecast to 2023” Gives industry size, top players and worldwide demand

Prevalence of Organ Failure Identified as Major Accelerators to the Organ Transplantation Market

Organ transplantation is the removal of organ or tissue from one individual and its placement in another. Organ transplantation can also be performed within the same individual, as tissues can be moved to a different location within the same body. Organ transplantation has become a major tool for the healthcare sector in recent decades, with organ transplantation providing a solution to many notable and concerning health issues such as nephritis and terminal heart conditions. Organ transplantation is a triumph of modern medicine and must be celebrated as one of the most ingenious solutions ever developed in the healthcare sector.

Also Read : https://www.medgadget.com/2019/12/organ-transplantation-market-size-worlds-top-10-industry-share-analysis-growing-at-9-8-cagr-during-forecast-2019-to-2023.html 

The Global Organ Transplantation Market, as per the study conducted by Market Research Future (MRFR), is expected to attain a compound annual growth rate of 9.8% during the forecast period of 2018 to 2023. An increasing number of organ transplantation surgeries undertaken globally is one of the major drivers of the organ transplantation market. Increasing prevalence of chronic diseases, advancements in technology, changing lifestyle of individuals, and the rising aging population are some of the other key factors influencing the growth of the global market.

However, at the same time, it is worth noting that the high treatment cost and increasing incidences of organ failure can severely hamper the projected growth of the market.

Organ Transplantation Market Leaders

• TransMedic, Inc. (US),
• Transonic (US),
• Novartis International AG (Switzerland),
• OrganOX Limited (UK),
• F. Hoffmann-La Roche Ltd. (Switzerland),
• Terumo Medical Corporation (US),
• Preservation Solutions, Inc. (US),
• Transplant Biomedical (UK),
• Accord Healthcare GmbH (Spain),
• Astellas Pharma, Inc (Japan),
• Pfizer, Inc. (US),
• Veloxis Pharmaceuticals A/S (Denmark),
• Bio Med Pvt. Ltd. (US),
• GlaxoSmithKline Plc. (UK),
• Sanofi (France)

Organ Transplantation Market Growth and Share Analysis by Regions

The regional segmentation of the organ transplantation market covers the following regions: Europe, Americas, Asia Pacific, and the Middle East and Africa.

America holds the largest share of the market in the global standings of organ transplantation. This is due to the increasing prevalence of chronic diseases. Other key factors influencing the growth of the market in this region are the rising aging population, an increase in the number of organ transplantation cases, and striking developments in technology.

Europe stands second in the global organ transplantation market due to various essential factors or drivers. The regional market is driven by the developed infrastructure, encouragement for the emergence of new organizations, and increasing expenditures on healthcare.

Asia Pacific is expected to grow at a notable pace in the near future and cement its position as one of the key regions in the global organ transplantation market. Factors such as fast-paced development in the healthcare industry, presence of a huge patient population pool, and the availability of skilled professionals are the major growth drivers of the market. However, in the Middle East and Africa region, the poor economical condition coupled with the limited growth of the healthcare sector is expected to be responsible for the meagre growth of the region.

Market Segmentation

The global organ transplantation market segmentation is done as per the following dynamics: type. End-users, products, and treatment.

By type, the market comprises of lungs, heart, liver, kidney, and others.

By products, the market segments into tissue products, organ preservation solutions, transplant diagnostics, and others.

By type of treatment, the market includes immunosuppressant, analgesic, and other. Immunosuppressant is narrowed down into mTOR inhibitor, calcineurin inhibitors, steroids, antiproliferative agents, and other. Whereas calcineurin inhibitors are divided into tacrolimus and cyclosporine. And, mTOR inhibitor is broken down into sirolimus and everolimus.

By type of transplant, the market includes allograft, xenograft, autograft, allotransplantation, xenotransplantation, and others.

By end users, the market comprises transplant centers, hospitals, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/organ-transplantation-market-915

About Market Research Future:

Market Research Future® has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Contact Us:

Market Research Future (MRFR)

528, Amanora Chamber

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Integrated Cardiology Devices Market is Growing Massively till 2022

 Market Research Future adds the “Integrated Cardiology Devices Market Research Report - Forecast to 2023” report to their unique collection.

The Global Integrated Cardiology Devices Market Report is Recently Published By Market Research Future Firm. Report include market exclusive analysis on the basis of industry size, recent trends and demand supply. Market analysis is available on MarketResearchFuture.com uniquely by 80+ pages information, 30+ tables and 30+ figures exclusively.

The Global Integrated Cardiology Devices Market is growing with a rapid pace. According to a recent study report published by the Market Research Future, the Global Integrated Cardiology Devices Market is booming and expected to gain prominence over the forecast period and is projected to grow a sound pace. The market is projected to demonstrate a sound growth by 2023, surpassing its previous growth records in terms of value with a sound CAGR during the anticipated period (2017-2023).

Integrated cardiology devices are equipment which surgeons use for critical cardiac surgeries. These modern devices are extensively utilised for early diagnosis ensuring better treatment of various cardiovascular diseases. In recent years, growth has been observed in the integrated cardiology devices. Increase prevalence of the cardiovascular diseases is the major driving factor for the market growth. According to World Health Organization, approximately 30% of the deaths across the globe are caused due to heart diseases. Moreover, growing adoption rates of minimally invasive surgeries favoured by continuous developments within the healthcare sector boost the market growth. However, factors such as lack of awareness and expensive treatment is estimated to restrain the market growth during the forecast period.

Also Read : https://www.medgadget.com/2019/01/integrated-cardiology-devices-market-will-see-explosive-growth-at-12-4-cagr-by-2022-demand-analysis-by-jude-medical-edwards-lifesciences-corporation-abbott-laboratories-johnson-and-johnso.html

The Global Integrated Cardiology Devices Market is expected to grow at a CAGR of 12.4% during forecasted period 2017-2023.

Segmentation 

The Global Integrated Cardiology Devices Market is segmented on the basis of types, applications and end users.

Based on types, the market is segmented as Cardiology EMR Software, EHR (Electronic health record), FFR (fractional flow reserve), Optical Coherence Tomography, others.

On the basis of application, they are segmented sudden cardiac arrest, internal monitoring, Cardiac resynchronization therapy, Cardiothoracic surgery, others. Cardiac Resynchronization Therapy (CRT) is an effective therapy in heart failure.

On the basis of end users, the market is segmented into catheterization laboratories, Hospitals and others.

Key Players:

Market Research Future (MRFR) recognizes the following companies as the key players in Integrated Cardiology Devices Market: There are plenty of large and small market players which operate in this market all over the globe.

• Medtronic (US),
• Boston Scientific Corporation (US),
• Jude Medical (US),
• Edwards Lifesciences Corporation (US),
• Abbott Laboratories (US),
• Johnson and Johnson (US),
• Getinge (Sweden),
• Terumo Corporation (Japan),
• Lepumedical (Bejing),
• Acrostak (Switzerland),
• Koninklijke Philips N.V. (Netherlands),.
• Athenahealth, Inc. (U.S)

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in Integrated Cardiology Devices Market and to maintain their market position.

In August, 2017- Medtronic, the global leader in medical technology, completed their acquisition of HeartWare International, Inc., a leading innovator of less-invasive, miniaturized, mechanical circulatory support technologies (MCS) for treating patients with advanced heart failure. HeartWare became part of the Heart Failure business within the Medtronic Cardiac Rhythm and Heart Failure division. Under the terms of the transaction, each outstanding share of HeartWare common stock was converted into the right to receive USD 58.00 in cash.

In January, 2017- Abbott completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena. The transaction provided Abbott with expanded opportunities for future growth and is an important part of the company’s ongoing effort to develop a strong, diverse portfolio of devices, diagnostics, nutritionals and branded generic pharmaceuticals.

In July, 2016- Boston Scientific Corporation acquired Cosman Medical, Inc., a privately held Burlington, Mass. manufacturer of radiofrequency ablation (RFA) systems. The Cosman Medical team and products became a part of the Boston Scientific Neuromodulation business, which offered a range of Spinal Cord Stimulator (SCS) systems to treat patients with chronic pain, and Deep Brain Stimulation systems for the treatment of Parkinson’s disease, dystonia and essential tremor.

In September, 2016- Johnson & Johnson announced that the company entered into a definitive agreement to acquire Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott Laboratories, for USD 4.325 billion in cash. AMO reported sales of USD 1.1 billion for 2015. The acquisition included ophthalmic products in three business segments: cataract surgery, laser refractive surgery and consumer eye health.

Regional Analysis:

The Americas accounts for a significant market share. High healthcare expenditure, rising number of the cardiac services, especially within the U.S. and Canada region are the major drivers for market growth within the region. Europe is the second largest market in the world. Growing medical devices industry and healthcare penetration drives the market within the region. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period due to its large medical devices industry. Asia Pacific region is expected to grow rapidly. On the other hand, the Middle East and Africa region holds the least market share.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/integrated-cardiology-devices-market-1189 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Worldwide EHR-EMR Market Ready To Set Outstanding Growth From 2020 To 2027

 Electronic health record (EHR)/electronic medical record (EMR) software is accountable for storing relevant data of patients including their medical history. This can prove valuable to doctors in coming to the right prognosis. The global EHR-EMR market report contains pertinent insights, trends, and opportunities for device manufacturers with ample data backed by statistics and news confirmed by reputed agencies. It outlines predictions for the period of 2017 to 2027 (forecast period).

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/819 

Market Scope

The global EHR-EMR market size is reportedly about to touch USD 42,427.27 million by 2027. It can exhibit a stellar CAGR of 5.82% over the forecast period. Benefits of EHR-EMR systems which can improve patient outcomes can drive its adoption greatly. According to the Health.IT website, an agency serving the U.S. government, close to 96% hospitals have adopted EHR-EMR systems in 2017. This is an indicator of healthcare organizations and their need to adopt advanced technology for improving patient experience.

Adoption of practice management software by private clinics with integrated EHR-EMR features which contain patient data as well as regulate patient queues for easy appointments can bode well for the market. The large patient volume can be handled with ease without any burden on the existing work staff. Micro factors such as high productivity and employee satisfaction can positively impact the global EHR-EMR market demand.

But high costs of implementation of EHR-EMR software and concerns of data privacy can hamper market growth.

Segmentation

The global EHR-EMR market is segmented by component, application, mode of delivery, and end-user.

On the basis of component, the market is divided into software, services & consulting, and hardware. The software segment is the expected to exhibit the fastest growth till 2027. It is expected to reach a value of USD 25,823.57 million by 2027. Software companies serving the EHR-EMR end-user base have animated patient cards, task donuts, and a separate dashboard to segregate the important data. Hardware for these systems include tablet PC, laptop, desktop, and workstations. All the hardware is adopted as per the comfort of employees and affordability of employers. The services & consulting segment comprises consultants adept at imparting product knowledge to clients and improving their processes and productivity rate. Offerings of customization are predicted to drive the segment growth during the forecast period.

Applications covered include general applications and specialty-based. Out of the two, the specialty-based segment is the fastest-growing at a CAGR of 6.02% during the forecast period. Doctors specializing in certain areas need specific systems or software tailored for their users. EHR-EMR software developers offer customized services to specialists with various templates suited for their practice. This segment is further segmented into neurology, radiology, cardiology, oncology, and others. The cardiology segment held the largest share of the specialty-based segment in the global EHR-EMR market in 2016. This can be attributed to the high rate of incidence of cardiovascular diseases. In 2015, coronary heart disease accounted for the deaths of close 366,000 people in the US, according to the Center for Disease Control & Prevention (CDC).

The mode of delivery comprises on-premises and cloud-based. The on-premises segment currently holds close to 55% share of the global EHR-EMR market. This can be attributed to the control given to end-users over storage and management of patient health data. On the other hand, the cloud-based segment can gradually have a lion’s share of the market owing to its ability to scale without additional costs.

By end-user, the global EHR-EMR market is segmented into diagnostic centers, hospital & clinics, and ambulatory care.

Regional Analysis

The Middle East & Africa (MEA), Americas, Europe, and Asia Pacific (APAC) are regions covered in the global EHR-EMR market report.

The Americas are anticipated to dominate the global market till 2027. The region comprises North America and South America, out of which North America held for a sizeable market share in 2017. Presence of leading market players and advanced healthcare infrastructure are major factors driving market share.

APAC can exhibit a CAGR of 6.77% during the forecast period owing to awareness of EMR systems and the importance of their adoption outlined by supportive government policies.

Competition

GE Healthcare, Allscripts Healthcare Solutions, Cerner Corporation, Advanced Data Systems Corporation, Athenahealth, Inc., AdvancedMD, eClinicalWorks, and others are major players of the global EHR-EMR market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/ehr-emr-market-819 

The Enteral Feeding Devices Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2023

 Market Highlights

The global enteral feeding devices market held a market value of USD 2,302.4 million in 2017 and is projected to grow at a CAGR of 6.1% over the forecast period. Enteral feeding is the direct delivery of nutrients into the gastrointestinal tract (GIT) via a tube which is placed into the duodenum, jejunum or stomach through mouth, nose or percutaneous route. Major factors driving the market growth are globally growing geriatric population coupled with the rising burden of chronic diseases, increasing shift from parenteral to enteral nutrition, and mounting incidence of preterm births. For instance, according to the World Health Organization (WHO), in 2001, chronic diseases contributed around 60% of the 56.5 million total reported deaths across the world and approximately 46% of the global burden of disease, which is projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide. In contrast, complications associated with enteral feeding devices including inadvertent dislodgement of tubes and stringent reimbursement policies are anticipated to restrain the market growth during the next five years. Mounting technological advancement in feeding pumps such as enhanced portable pump designs with reduced risk of complications and is augmenting the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7828 

Regional Analysis

The global enteral feeding devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas would command the market over the forecast period pertaining to the presence of sophisticated medical and healthcare infrastructure and market value contributors, changing lifestyle, and the rising burden of cancer, and other noncommunicable diseases (NCDs). The American Cancer Society stated that in 2018, about 9,220 new cases of colon cancer have diagnosed in the US. 

Europe would be the second-largest value contributor in the enteral feeding devices market owing to the Asia-Pacific would represent the profitable market growth during the forecast period due to growth in geriatric population, rising incidence of oral cancer, and increasing awareness about enteric feeding devices, and surging number of hospital admissions in China, India, Japan, and Australia. The World Health Organization stated that in 2018, the incidence of oral cancer was within the top three of all cancers in a few Pacific Asian countries.

The Middle East & Africa has the least share of the global enteral feeding devices market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Segmentation

The global enteral feeding devices market has been segmented into product, age group, indication, end user, and region.

By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

On the basis of age group, the market has been divided into adults and pediatrics.

By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others.

Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs).

Key Players

Some of the spearheading players in the global enteral feeding devices market are Medtronic plc, Cook Medical, B. Braun Melsungen AG, Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company (BD), Fresenius Kabi AG, Danone Nutricia, Nestlé, CONMED Corporation, Moog, Inc., Halyard Health, Inc., and Vygon SA.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/enteral-feeding-devices-market-7828